Furoscix® (furosemide) – Expanded indication
March 7, 2025 - scPharmaceuticals announced the FDA approval of Furoscix (furosemide), for the treatment of edema in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.
Download PDF
